<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7038234\results\search\drugs\results.xml">
  <result pre="selectivity indexes over 1,000. The results indicated that ouabain and" exact="digoxin" post="blocked the JEV infection at the replication stage by"/>
  <result pre="drug. KEYWORDS high-content screening (HCS) Japanese encephalitis virus (JEV) ouabain" exact="digoxin" post="Na+/K+-ATPase Funding National Key Research and Development Program of"/>
  <result pre="(8), N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) (9), indirubin (10), manidipine (11)," exact="chlorpromazine" post="(12), etanercept (13), and minocycline (14), few therapies beyond"/>
  <result pre="derivative (SCH 16) (9), indirubin (10), manidipine (11), chlorpromazine (12)," exact="etanercept" post="(13), and minocycline (14), few therapies beyond intensive supportive"/>
  <result pre="(9), indirubin (10), manidipine (11), chlorpromazine (12), etanercept (13), and" exact="minocycline" post="(14), few therapies beyond intensive supportive care to treat"/>
  <result pre="selected for the second screening because of their solubility in" exact="dimethyl sulfoxide" post="(DMSO) at room temperature and absence of any obvious"/>
  <result pre="(Fig. 2A and B). Among the 8 compounds, ouabain and" exact="digoxin" post="were subjected to further investigation because of their high"/>
  <result pre="at least two independent experiments. Antiviral effects of ouabain and" exact="digoxin" post="in different cell lines and viruses. For AT31 infection"/>
  <result pre="cell lines and viruses. For AT31 infection of Vero cells," exact="digoxin" post="(392 nM) and ouabain (196 nM) displayed inhibition rates &amp;gt;90%; the"/>
  <result pre="SA14 reproduction could be greatly inhibited when the concentration of" exact="digoxin" post="and ouabain reached 392 nM and 98 nM, respectively, Simultaneously, the"/>
  <result pre="FIG 3 Validation of the antiviral effects of ouabain and" exact="digoxin" post="in different cell lines and virus strains. The antiviral"/>
  <result pre="different cell lines and virus strains. The antiviral effects of" exact="digoxin" post="and ouabain against two JEV strains (AT31 and SA14)"/>
  <result pre="assessed by qRT-PCR. (G to J) The antiviral effects of" exact="digoxin" post="and ouabain against two JEV strains in Huh-7 cells"/>
  <result pre="*, P &amp;lt; 0.05. Under the same conditions of infection, ouabain and" exact="digoxin" post="robustly inhibited AT31 and SA14 virus production in a"/>
  <result pre="the two cell lines (Fig. 3G to J). Ouabain and" exact="digoxin" post="inhibit JEV infection during viral RNA synthesis. To determine"/>
  <result pre="was performed (Fig. 4A). As shown in Fig. 4B, neither" exact="digoxin" post="nor ouabain showed suppression of JEV in virucidal treatments"/>
  <result pre="during treatment. Most importantly, when added posttreatment, both ouabain and" exact="digoxin" post="exerted full inhibitory effects on JEV infection, suggesting that"/>
  <result pre="illustration of the time-of-addition experiment. (B) The inhibitory effects of" exact="digoxin" post="and ouabain with the indicated concentration in each group,"/>
  <result pre="Huh-7 cells transfected with the JEV replicon were treated with" exact="digoxin" post="and ouabain, respectively, and luciferase activities were determined as"/>
  <result pre="infection at the replication stage. JEV inhibition with ouabain and" exact="digoxin" post="occurs via Na+/K+-ATPase. Na+/K+-ATPase is the only target of"/>
  <result pre="experimental conditions, the results of ouabain action were consistent with" exact="digoxin" post="(Fig. 5C and D), which indicated that the JEV-inhibiting"/>
  <result pre="correlated with KCl. These results confirm that both ouabain and" exact="digoxin" post="exert the antiviral effect by targeting the Na+/K+-ATPase. FIG"/>
  <result pre="by targeting the Na+/K+-ATPase. FIG 5 Inhibition of JEV with" exact="digoxin" post="and ouabain occurs via Na+/K+-ATPase. Vero cells infected with"/>
  <result pre="arrhythmias and hypotension for more than 200 years. Recently, ouabain and" exact="digoxin" post="have been proven to inhibit different kinds of viruses,"/>
  <result pre="variants by serial passaging of JEV using increasing concentrations of" exact="digoxin" post="and ouabain, respectively. However, no adaptive mutant was found"/>
  <result pre="the associated Harmony 3.5 software. Antiviral effects of ouabain and" exact="digoxin" post="with different cell lines and virus strains. Vero, Huh-7,"/>
  <result pre="for 1 h (0 to 1 h). Ouabain (10 μM) and" exact="digoxin" post="(10 μM) were incubated with the cells for 1 h"/>
 </snippets>
</snippetsTree>
